Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 35Myeloid 24Lymphoid 20Plasma cell 11Classical hematology 8Sarcoma 7Dermatologic 7Other neoplasm 2Thoracic 1CNS 1

Conditions

Thymoma 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Myelodysplastic Syndromes 1Melanoma 1Lung Neoplasms 1Leukemia 1Kidney Neoplasms 1Graft vs Host Disease 1Carcinoma, Renal Cell 1Breast Neoplasms 1Anemia, Refractory 1

Interventions

Radiotherapy 1Methylprednisolone 1Melphalan 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Busulfan × Thoracic × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡